Cervical cancer Trials in New York, United States
Conditions / Cervical cancer / New York, United States
Cervical cancer has been the subject of sustained clinical investigation across multiple research sites.
78 total trials for this combination
Showing top 10 of 78 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00578006 | Internet-based System for Cancer Patients to Self-report Toxicity | COMPLETED | NA |
| NCT06203106 | NYSCF Scientific Discovery Biobank | RECRUITING | — |
| NCT05311618 | Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors | ACTIVE_NOT_RECRUITING | PHASE1 |
| NCT02430948 | Improving Compliance With Medical Testing Guidelines | COMPLETED | NA |
| NCT06293898 | Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors | RECRUITING | PHASE1 |
| NCT06172478 | A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors | RECRUITING | PHASE2 |
| NCT05983432 | Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors | RECRUITING | PHASE1 |
| NCT04644068 | Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2 |
| NCT00587964 | Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain Metastases | COMPLETED | PHASE2 |
| NCT05215574 | Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors | ACTIVE_NOT_RECRUITING | PHASE1 |